The UMC Southwest Cancer Center is at forefront of treatment technologies. We offer the latest cutting-edge technology and radiosurgery equipment not available anywhere else in the region. Most of all we offer all of this to give patients the best in treatment options.
This treatment device uses low-intensity electric fields to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years old or older. We often use this in conjunction with radiation therapy.
Xofigo Radium 223
This is a radioactive injection used to treat prostate cancer that no longer responds to hormonal or surgical treatment. It is also for men whose prostate cancer has spread to the bones.
SpaceOAR is a water-based gel injected to separate the prostate from the rectum. It is best used during radiation treatments for prostate cancer and allows for less exposure to other organs.
Chromic Phosphate (P32)
P32 is a radiopharmaceutical used to treat cancer. It is given by injection to treat cancer in certain organs, such as the ovaries and prostate.
4D CT is an advanced imaging method that makes CT scans quicker and more accurate. It uses new technology that captures the location and movement of tumors and the body (organs).
Intrafraction monitoring allows us to monitor movement of the prostate during radiation treatments. This ensures quicker, more accurate radiation delivery.
Optical Surface Monitoring System (OSMS)
Our OSMS is a Stereotactic Radiosurgery Intracranial solution, designed to ensure treatments are delivered with precision. I projects a grid onto patients to allow us to monitor movement; if movement is detected, then the treatment delivery pauses.
TrueBeam Linear Accelerator
The TrueBeam system is an advanced radiotherapy system engineered to deliver powerful cancer treatments with accuracy and precision. This technology allows UMC Southwest Cancer Center physicians to treat many types of cancers. It also is quicker: what once took 10 to 30 minutes can now be completed in less than two minutes.
The Delta4 Discover is a brand new quality assurance device, and UMC was the first to order it! It allows us to test the radiation in our machines while our patients are receiving treatment to ensure the correct dosage is given.
We use the DeltaPhantom+ system in conjunction with intensity-modulated radiation therapy (IMRT) and similar treatments, to verify the accuracy and efficiency of treatment. It is the only system that measures dose distribution in the isocentric region, which allows physicians to know how much radiation is being delivered